This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70883199
rdf:type
wikibase:Item
schema:description
article scientifique publié en 1995 наукова стаття, опублікована в листопаді 1995 scientific article published on 01 November 1995 im November 1995 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel artículu científicu espublizáu en payares de 1995
p:P577
wds:Q70883199-DE3F485A-999A-4A59-8DCD-F13FADD153BF
wdt:P577
1995-11-01T00:00:00Z
p:P407
wds:Q70883199-0A7D10FD-E0D4-44A8-B258-B27DD656B899
wdt:P407
wd:Q1860
p:P2093
wds:Q70883199-A8F9A192-08F3-41E5-97F5-BECEDEF9DBC1 wds:Q70883199-3B99E8E7-523A-4DA4-B8AD-F78B0B848300 wds:Q70883199-074E3B96-29A7-408D-9842-73E2F5D10C1D
wdt:P2093
O Ishikawa M Sato Y Miyachi
rdfs:label
The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma
skos:prefLabel
The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma
schema:name
The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma
p:P1476
wds:Q70883199-3FE68801-2775-4359-8595-BB181440831D
wdt:P1476
The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma
p:P304
wds:Q70883199-AA1554C4-AA92-4A6B-803F-25423D72A30D
wdt:P304
810-813
p:P31
wds:Q70883199-5C2CA633-C8CF-411D-B7A8-96FC958893C5
wdt:P31
wd:Q13442814
p:P698
wds:Q70883199-11E1A234-494B-4E8F-8044-4CD1AE1B2C95
wdtn:P698
n10:8555042
wdt:P698
8555042
p:P1433
wds:Q70883199-812A43B8-7CA7-4ED0-8375-0C3A16F46222
wdt:P1433
wd:Q4970191
p:P433
wds:Q70883199-6A1E22AF-D6DD-4E52-9C60-3015E1549851
p:P478
wds:Q70883199-938ACF0A-02B2-4B21-8479-5FA918FC4F4C
wdt:P433
5
wdt:P478
133
p:P356
wds:Q70883199-675FFF85-7060-4CEB-A8EA-776CCE474654
wdtn:P356
n9:J.1365-2133.1995.TB02764.X
wdt:P356
10.1111/J.1365-2133.1995.TB02764.X